Johnson & Johnson
Slovenia on Wednesday temporarily suspended vaccinations with Johnson & Johnson after a 20-year-old woman died of a brain haemorrhage and blood clots just days after getting a jab.
The Johnson & Johnson Covid vaccine is more effective when given as a two-dose regime, according to new data released by the company on Tuesday.
Hope of an effective Human Immuno-deficiency Virus (HIV) vaccine may have been dashed, as researchers announced Tuesday that an advanced trial in Africa had been stopped after data showed...
Johnson & Johnson's highly anticipated HIV vaccine failed to demonstrate adequate protection in a clinical trial involving more than 2,600 young women in sub-Saharan Africa, the company and US health authorities said Tuesday.
The African Export-Import Bank (Afreximbank), which facilitated the procurement of the Johnson & Johnson (J&J), Janssen Pharmaceuticals’ vaccine, says the vaccine...
Three new candidate drugs are being tested in the latest phase of global Solidarity clinical trials to find effective treatments against COVID-19, the World Health Organisation...
South African pharmaceutical company Aspen said Monday it was releasing its first batch of African-produced Covid-19 vaccines under a licensing deal with the US giant Johnson & Johnson. The Durban-based company said the first batch was leaving its factory in Gqeberha, formerly known as Port Elizabeth. In a statement, it described the release as a…
The National Agency for Food and Drug Administration and Control (NAFDAC), yesterday, granted conditional Emergency Use Authorisation (EUA) for Janssen (Johnson & Johnson)
The National Agency for Food and Drug Administration and Control (NAFDAC) has approved the use of the Johnson & Johnson COVID-19 vaccine in Nigeria to
Germany on Monday opened access to Johnson & Johnson's coronavirus vaccines to all adults, lifting a priority system determining who gets the jabs first.
South Africa announced Monday it would shortly resume using Johnson & Johnson anti-Covid vaccines, two weeks after the jab was suspended to vet risks over blood clots.
Drugmakers including Johnson & Johnson on Tuesday denied claims they helped fuel the deadly opioid epidemic in the United States through deceptive marketing that downplayed addiction risks, as the trial in a lawsuit filed by several municipalities got underway.